Terapia S.A.

Cluj-Napoca 36 trials 2 recruiting

36 Registered trials

2 Currently recruiting

Organisation

Terapia S.A.

Location

Cluj-Napoca, Romania

Identifier

ORG-100000123

Address

Strada Fabricii Nr. 124, 400640, Romania

Departments

Clinical Pharmacology and Pharmacokinetics
CPP Department

Clinical trials at this site (36)

Search interface

An open label, balanced, randomized, two-treatment, two-period, two-sequence, single dose crossover bioequivalence study comparing Enzalutam… Ended

2024-518211-20-00 Prostate cancer 2 2025-04-14
An open label, balanced, randomized, two-treatment, two-period, two-sequence, single-dose, crossover, bioequivalence study comparing Brivara… Ended

2024-516500-42-00 Epilepsy 2 2025-03-13
An open label, balanced, randomized, two-treatment, two-period, two-sequence, single dose crossover bioequivalence study comparing Bosutinib… Ended

2024-516489-12-00 myeloid leukemia 2 2025-01-31
An open label, balanced, randomized, two-treatment, two-period, two-sequence, single-dose, crossover, bioequivalence study comparing Dextroa… Ended

2023-509874-48-00 ADHD 2 2025-01-09
An open label, balanced, randomized, two-treatment, two-period, two-sequence, single dose crossover bioequivalence study comparing Lamotrigi… Ended

2024-513106-62-00 Bipolar disorder 2 2024-12-16
An open label, balanced, randomized, single dose, two treatment, two period, two sequence, crossover, bioequivalence study comparing Empagli… Ended

2024-513340-28-00 Diabetes 2 2024-11-19
An open label, balanced, randomized, two-treatment, four period, two-sequence, multiple-dose (steady-state), fully-replicate crossover bioeq… Ended

2024-512770-10-00 Rheumatoid arthritis, ulcerative colitis, atopic dermat 2 2024-10-07
An open label, balanced, randomized, two-treatment, two-period, two-sequence, single-dose, crossover, bioequivalence study comparing Upadaci… Ended

2024-512771-12-00 Axial spondyloarthritis 2 2024-09-17
An open label, balanced, randomized, two-treatment, two-period, two-sequence, single-dose, crossover, bioequivalence study comparing Upadaci… Ended

2024-512773-27-00 Rheumatoid arthritis, ulcerative colitis, atopic dermat 2 2024-08-19
An open label, balanced, randomized, single dose, two treatment, two period, two sequence, crossover, bioequivalence study comparing Lacosam… Ended

2023-507991-32-00 Epileptic seizures 2 2024-07-25
An open label, balanced, randomized, single dose, two treatment, two period, two sequence, crossover, bioequivalence study comparing Ivacaft… Ended

2023-508115-23-00 Cystic Fibrosis 2 2024-02-20
An open label, balanced, randomized, single dose, two treatment, two period, two sequence, crossover, bioequivalence study comparing Dapagli… Ended

2023-506408-18-00 diabetes 2 2023-11-21